The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, October 11, 2023
Family Dollar is initiating a voluntary retail-level product recall of certain over-the-counter drugs and medical devices regulated by the FDA.
read more
Tuesday, September 19, 2023
Nexcella, Inc., a clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other ...
read more
Thursday, August 17, 2023
Croda Pharma introduced a range of new bioprocessing detergents optimised for viral inactivation and cell lysis.
read more
Thursday, August 17, 2023
The life science group Sartorius and Repligen Corporation announced the launch of an integrated bioreactor system that incorporates Repligen XCell® ...
read more
Lifera, a biopharmaceutical company in Saudi Arabia together with Sanofi, and Arabio announced the signing of a Memorandum of Understanding (MOU), ...
read more
OBiO Technology Corp., Ltd., a gene and cell therapy CDMO in China, and Univercells Technologies, a lprovider of novel biomanufacturing technologies ...
read more
Thermo Fisher Scientific has opened a new sterile drug facility in Singapore that will better enable customers to deliver new medicines and vaccines ...
read more
Camber Pharmaceuticals is voluntarily recalling lot # E220182 of Atovaquone Oral Suspension, USP 750mg/5mL to the Consumer/User level, due to the ...
read more
Wednesday, March 01, 2023
The FDA announced that it has taken action to restrict the unlawful entry of xylazine active pharmaceutical ingredients and finished dosage form drug ...
read more
Tuesday, January 10, 2023
Spectrum Laboratory Products, Inc. is voluntarily recalling three lots of Epinephrine (L-Adrenaline) USP, a bulk active pharmaceutical ingredient (API...
read more
Orchard Therapeutics announced the FDA cleared its Investigational New Drug (IND) application for OTL-203, a hematopoietic stem cell (HSC) gene ...
read more
Monday, November 21, 2022
The US FDA issued warning letters to seven companies for illegally selling dietary supplements that claim to cure, treat, mitigate or prevent ...
read more
Friday, November 11, 2022
AstraZeneca announced the availability of the first rare disease therapy from Alexion, AstraZeneca’s Rare Disease group, in China. The availability of...
read more
Wednesday, November 09, 2022
The FDA Pulmonary-Allergy Drugs Advisory Committee (PADAC) has voted 16 to 1 that the data support a favorable benefit risk assessment for the use of ...
read more
Thursday, October 20, 2022
AAPS will be the exclusive authority advising RX on scientific focus areas that affect the approximate 8,000-person event beginning in spring 2023 ...
read more